 |
 |

Ablative Therapy of Malignant Liver NeoplasmReply
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
In reply
Thank you for your comments to our recently published article. The purpose of our study was to perform a systematic review of the current literature on RFA. We had strict criteria as to which studies could be included. We agree that there is evidence that combining hepatic blood flow interruption with RFA has been shown to reduce the rate of tumor recurrence and increase the size of the lesion that is able to be ablated, and the long-term result appears better than with radiofrequency alone. At the time of preparation of our review, there was no such study available that fit our inclusion criteria.
In terms of long-term survival for patients undergoing one of these procedures, there are few long-term data yet available. Many studies have quoted figures for 5-year survival, yet these are often actuarial. This applies to the study by Pacella et al,1 so we have . . . [Full Text of this Article] AUTHOR INFORMATION
Guy J. Maddern, PhD
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
RELATED ARTICLES
Ablative Therapy of Malignant Liver Neoplasm
M. Badruddoja
Arch Surg. 2006;141(9):947.
EXTRACT
| FULL TEXT
Radiofrequency Ablation of Liver Tumors: A Systematic Review
Leanne M. Sutherland, John A. R. Williams, Robert T. A. Padbury, David C. Gotley, Bryant Stokes, and Guy J. Maddern
Arch Surg. 2006;141(2):181-190.
ABSTRACT
| FULL TEXT
|